In 1978, Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., genetically engineered bacteria through a technology referred to as recombinant DNA. This technology resulted in the development of artificial human insulin and hgh. Today, City of Wish is a leader in islet cell transplantation, an investigational procedure for the procedure for type 1 diabetes. Related StoriesType 2 diabetes drug reduces hospitalizations, death from center failureStudy suggests need for specific treatment plans for adolescents with onset type 2 diabetesStudy finds high prevalence of dehydration in older people living in UK care homesNearly 26 million people in the U.S. Have diabetes and an estimated 79 million U.S. Adults have prediabetes, based on the Centers for Disease Control and Prevention . If these tendencies continue, the CDC estimates that as many as one in three U.S.In a Might 1 letter to CMS Performing Administrator Marilyn Tavenner, Rep. Renee Ellmers expressed concern about the meaningful use requirements within the 2009 HITECH Take action .org with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan healthcare policy research organization unaffiliated with Kaiser Permanente.. BioSystem Advancement announces the launch of AssayMAP MAb Titer Assay BioSystem Development, LLC., a privately held life technology analytics company, announces the discharge of the AssayMAP MAb Titer Assay for measuring antibody item concentrations in bioprocess samples. Antibody titer assays certainly are a crucial bottleneck in biotherapeutic process advancement.